SCHEMBL6867573

SCHEMBL6867573

COc1ccc(CNC(=O)N[C@H]2CC[C@@H](Nc3nc4c(c(N(C)C)n3)CCCC4)CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
RAB9A P51151 3/20 0.57
NPC1 O15118 1/20 0.57
MCHR1 Q99705 3/20 0.47
ADRA2A P08913 1/20 0.47
HRH3 Q9Y5N1 1/20 0.45
MAPK1 P28482 1/20 0.44
HPGD P15428 2/20 0.43
TSHR P16473 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 1/20 0.42
RXFP1 Q9HBX9 1/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867578 1.00 SMN1; SMN2 (0.57) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6875039 0.90 EPHX1 (0.51) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6875033 0.90 EPHX1 (0.51) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6880005 0.90 RAB9A (0.55) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6879998 0.90 RAB9A (0.55) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6875715 0.89 PKM (0.45) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6875718 0.89 PKM (0.45) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6875707 0.89 MCHR1 (0.44) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6458561 0.89 MCHR1 (0.50) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A
SCHEMBL6458549 0.89 MCHR1 (0.50) SMN1; SMN2RAB9ANPC1MCHR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed